Results 41 to 50 of about 1,191,068 (306)

CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. [PDF]

open access: yesPLoS ONE, 2017
OBJECTIVES:Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features.
Sofi Isaksson   +7 more
doaj   +1 more source

Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis [PDF]

open access: yes, 2018
The diagnosis of central nervous system (CNS) histoplasmosis is often difficult. Although cerebrospinal fluid (CSF) (1,3)-β-d-glucan (BDG) is available as a biological marker for the diagnosis of fungal meningitis, there are limited data on its use for ...
Albers, Amanda   +12 more
core   +2 more sources

Erratum: predictors of malignancy in pancreatic head mass: a prospective study

open access: yesThe Pan African Medical Journal, 2016
This erratum corrects ''Predictors of malignancy in pancreatic head mass: a prospective study'' The Pan African Medical Journal. 2011;9:30.
The Pan African Medical Journal
doaj   +1 more source

Comparison of the AIMS65 Score with Other Risk Stratification Scores in Upper Variceal and Nonvariceal Gastrointestinal Bleeding

open access: yesGut and Liver, 2018
Background/AimsTo determine the prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in gallbladder cancer (GBC) during palliative chemotherapy.Methods : One hundred and twenty-three patients with pathologically confirmed
Gonçalo Alexandrino   +2 more
doaj   +1 more source

Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis

open access: yesGastroenterology Research and Practice, 2018
Background. CA 19-9 and carcinoembryonic antigen (CEA) are widely used for the diagnosis of pancreatic cancer. The purpose of the present study was to compare the diagnostic value of CA 19-9 with CEA for pancreatic cancer. Methods. The studies were obtained from electronic searches conducted in PubMed, Embase, and Cochrane Library databases until ...
Haibo Xing   +6 more
openaire   +3 more sources

Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy

open access: yesGut and Liver, 2018
Background/AimsTo determine the prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in gallbladder cancer (GBC) during palliative chemotherapy.Methods : One hundred and twenty-three patients with pathologically confirmed
Jae Woo Lee   +8 more
doaj   +1 more source

Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue [PDF]

open access: yesCancer, 1987
In 115 primary colorectal carcinomas and 64 normal colorectal mucosa specimens the concentrations of carcinoembryonic antigen (CEA), CA 19-9, and CA 125 were measured. The determinations were performed in cytosols by use of radioimmunometric and enzymeimmunometric assays and related to the wet tissue weight.
A, Quentmeier   +4 more
openaire   +2 more sources

Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer

open access: yesThe International Journal of Biological Markers, 1995
In order to assess the utility of the tumor-associated antigen CA 72-4 in the diagnosis and monitoring of gastric cancer, this tumor marker was measured preoperatively in 718 patients.
F. Safi, V. Kuhns, H.G. Beger
doaj   +1 more source

Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions

open access: yesThe Turkish Journal of Gastroenterology, 2014
Background/Aims: Despite the presence of many diagnostic methods, the differential diagnosis between benign and malignant biliary obstructions is still not easy.
Ali Tüzün İnce   +9 more
doaj   +1 more source

Extreme elevation of CA19-9 in patient with endometriosis-associated cancer: A brief report and review of the literature

open access: yesCurrent Problems in Cancer: Case Reports, 2023
CA 19-9 (carbohydrate antigen 19-9) is used as a biomarker for hepatobiliary cancer and is generally not considered helpful in the evaluation of gynecologic cancer.
Maia Drasin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy